Medicaid Prevalence and Opioid Use Disorder Treatment Access Disparities.

When Medicaid is a common source of insurance within the local population, buprenorphine providers are much less likely to discriminate between Medicaid and privately insured prospective patients. Efforts to enhance equitable access across patient groups are perhaps best targeted where Medicaid prevalence is lower. This article is protected by copyright. All rights reserved.